The European Medicines Agency (EMA) has approved the use of Bavarian Nordic’s mpox vaccine in adolescents, increasing the ...

Mpox, declared a global public health emergency by WHO, has disproportionately affected children and adolescents ...

EU drug regulator approves use of Bavarian Nordic's mpox vaccine, Imvanex for adolescents: Copengagen, Denmark Saturday, September 21, 2024, 10:00 Hrs [IST] Bavarian Nordic A/S, a ...

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in at-risk communities.

The UN Children’s Fund, UNICEF, issued an urgent appeal on Friday for nearly $59 million to support efforts to halt the rapid ...

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS ...

With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years.

Kajeet and Avery Telehealth announced a strategic partnership. The FDA has approved Apple’s sleep apnea detection feature.

Health Minister of Indian state of Kerala, Veena George, said on Thursday that genome sequencing will be conducted to ...

The Democratic Republic of Congo, the epicenter of an mpox outbreak, on Thursday, received its first vaccines — almost half ...

The FDA’s priority review voucher program for rare pediatric diseases is set to lapse on Sept. 30 without congressional intervention.

Mpox (formerly known as monkeypox) is back in the news. As of early September, the World Health Organization has reported ...